FRANKLIN LAKES, N.J., March 13 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) announced today that it has agreed to sell $300 million aggregate principal amount of 6-1/8 percent senior notes due March 15, 2013 and $1.2 billion aggregate principal amount of 7-1/8 percent senior notes due March 15, 2018 in an underwritten public offering. Citi, J.P. Morgan Securities Inc., Banc of America Securities LLC and Barclays Capital Inc. are acting as representatives of the several underwriters.
Medco intends to use the net proceeds from the offering to repay
borrowings under its senior unsecured revolving credit facility used to
fund the acquisition of PolyMedica Corporation in October 2007. The
offering is expected to close on March 18, 2008. The prospectus supplement
and accompanying prospectus related to the offering of the notes may be
obtained by contacting:
Citigroup Global Markets Inc.
Brooklyn Army Terminal,
140 58th Street, 8th Floor,
Brooklyn, NY 11220
Tel: (877) 858 5407
J.P. Morgan Securities Inc.
270 Park Avenue, 8th Floor,
New York, New York, 10017
Tel: (212) 834-4533
Banc of America Securities LLC
Capital Markets Operations
100 West 33rd Street, 3rd Floor
New York, NY 10001
Tel: (800) 294-1322
Barclays Capital Inc.
200 Park Avenue
New York, NY 10166
Attention: Fixed Income Syndicate
Tel: (888) 227-2275
Electronic copies of the prospectus supplement and accompanying prospectus are also available on the Securities and Exchange Commission Web site at http://www.sec.gov.
This press release does not constitute an offer to sell
|SOURCE Medco Health Solutions, Inc.|
Copyright©2008 PR Newswire.
All rights reserved